Article
Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS
2025-03-10
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is characterised by motor neuron (MN) death; however, astrocytes play a key role in disease pathogenesis. Developments in the field of artificial intelligence (AI) have the potential to impact drug discovery in multiple ways, including the rapid identification of drug repurposing candidates. A combination of natural language processing and deep learning algorithms was used to ge...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c862551e-8a08-56ed-bef3-5cbb349c9ff1
- DOI
- 10.1101/2025.03.06.641147
